Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Net Income: 2023-2025

Historic Net Income for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to -$2.0 million.

  • BioLineRx's Net Income rose 45.04% to -$2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$7.7 million, marking a year-over-year increase of 80.04%. This contributed to the annual value of -$11.3 million for FY2024, which is 76.25% up from last year.
  • Latest data reveals that BioLineRx reported Net Income of -$2.0 million as of Q2 2025, which was down 2.84% from -$2.0 million recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Net Income registered a high of $54,000 during Q4 2024, and its lowest value of -$19.5 million during Q4 2023.
  • For the 3-year period, BioLineRx's Net Income averaged around -$6.3 million, with its median value being -$3.8 million (2024).
  • Data for BioLineRx's Net Income shows a peak YoY soared of 100.28% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows BioLineRx's Net Income stood at -$19.5 million in 2023, then soared by 100.28% to $54,000 in 2024, then skyrocketed by 45.04% to -$2.0 million in 2025.
  • Its Net Income was -$2.0 million in Q2 2025, compared to -$2.0 million in Q1 2025 and $54,000 in Q4 2024.